Appropriate discontinuation of medications at the end of life: A need to establish consensus criteria

被引：20

作者：

Lee, Seina P. ^{[1
]}

Bain, Kevin T.

Maio, Vittorio

机构：

[1] Ortho McNeil Janssen Sci Affairs LLC, Titusville, NJ USA

[2] Omnicare Co, ExcelleRx Inc, Dept Qual Outcomes, Philadelphia, PA USA

[3] Jefferson Med Coll, Dept Hlth Policy, Philadelphia, PA USA

来源：

AMERICAN JOURNAL OF MEDICAL QUALITY | 2007年 / 22卷 / 06期

关键词：

D O I：

10.1177/1062860607308145

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

引用

页码：393 / 394

页数：2

共 5 条

[1] Drug interactions in palliative care [J].

Bernard, SA ;

Bruera, E .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) :1780-1799

[2] Defining quality of care [J].

Campbell, SM ;

Roland, MO ;

Buetow, SA .

SOCIAL SCIENCE & MEDICINE, 2000, 51 (11) :1611-1625

[3] Adverse events after discontinuing medications in elderly outpatients [J].

Graves, T ;

Hanlon, JT ;

Schmader, KE ;

Landsman, PB ;

Samsa, GP ;

Pieper, CF ;

Weinberger, M .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (19) :2205-2210

[4] Reconsidering medication appropriateness for patients late in life [J].

Holmes, HM ;

Hayley, DC ;

Alexander, GC ;

Sachs, GA .

ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (06) :605-609

[5]

*WHO EXP COMM, 1990, TECHN REP SER, V804

← 1 →